Turn on ye ole Javascript to add ratings in this low-budg app.

Link to this page
← All panel ideas
Title:

Conversations With A Brick Wall: Social Media In Healthcare

Your vote:
Yes No
Organizer:
Amber Benson, imc²
Description:
Are healthcare marketing and social media contraindicated? Is it possible to create authentic conversations online when the FDA is eavesdropping? Learn how to create engaging, trust-building social media strategies for healthcare consumers that won't result in a warning letter or a congressional hearing.
Questions
Answered:
  1. What is a regulated industry?
  2. Can I just ask for forgiveness instead of permission?
  3. Just how risky is user-generated content?
  4. Can user-generated content be used in regulated industries?
  5. Are peer-to-peer communications possible?
  6. How fast can monitored user-generated content get posted?
  7. How long is too long to wait to see your comments/questions?
  8. Is the pharmaceutical industry the only one with an issue?
  9. Is there a way to meet medical, regulatory and legal requirements and serve the consumer?
  10. Has anyone successfully done this?
Level:
Intermediate
Category:
Advertising, Blogging, Community / Online Community, Social Networking, User Generated Content
Type:
Dual
Event:
Interactive 2010
Amber Benson
on 17/8/09
Attention healthcare marketers: Ever wanted work to pay for your trip to SXSW? Vote for my panel. We'll have a hot time in Austin and you can write it off as a business expense. :)
Erica Mauter
on 18/8/09
As an employee of the pharma industry, I'm very much looking forward to discussion of this topic. The level of regulation is (or at least feels) prohibitive to the grassroots, bottom-up type of social media presence you see cropping up by ground-level employees in other industries. The company/customer (patient) relationship is also very different than it is for consumer products. Throw in the topic of direct-to-consumer marketing for pharmaceuticals. It's a particularly tricky thing to navigate in this industry.

(I left this same comment on another panel addressing the specific case of the pharmaceutical industry. I really hope one or both of these panels makes it to the conference.)
Link to this page
← All panel ideas
Developed for SXSW by Lindsey Simon